We also found IRF8 expression was decreased in the blood pre-DCs of pancreatic cancer patients (Fig. 6f) and the extent of IRF8 downregulation correlated with blood pre-DC numbers (Fig. 6g). Here, IRF8 is linked to pancreatic neoplasm.